Histone deacetylases and their inhibitors in inflammatory diseases

被引:18
作者
Zhang, Sen-Yu [1 ]
Zhang, Li-Ying [1 ]
Wen, Ri [1 ]
Yang, Ni [1 ]
Zhang, Tie-Ning [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Pediat, PICU, Shenyang 110004, Peoples R China
关键词
Histone deacetylase; Inflammation; Disease; Drugs; Review; SUBEROYLANILIDE HYDROXAMIC ACID; VERSUS-HOST-DISEASE; ACUTE LUNG INJURY; HDAC INHIBITORS; CLASS-I; RHEUMATOID-ARTHRITIS; EPIGENETIC ENZYMES; LIVER-FAILURE; EXPRESSION; TRICHOSTATIN;
D O I
10.1016/j.biopha.2024.117295
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Despite considerable research efforts, inflammatory diseases remain a heavy burden on human health, causing significant economic losses annually. Histone deacetylases (HDACs) play a significant role in regulating inflammation (via histone and non-histone protein deacetylation) and chromatin structure and gene expression regulation. Herein, we present a detailed description of the different HDACs and their functions and analyze the role of HDACs in inflammatory diseases, including pro-inflammatory cytokine production reduction, immune cell function modulation, and anti-inflammatory cell activity enhancement. Although HDAC inhibitors have shown broad inflammatory disease treatment potentials, their clinical applicability remains limited because of their non-specific effects, adverse effects, and drug resistance. With further research and insight, these inhibitors are expected to become important tools for the treatment of a wide range of inflammatory diseases. This review aims to explore the mechanisms and application prospects of HDACs and their inhibitors in multiple inflammatory diseases.
引用
收藏
页数:18
相关论文
共 208 条
[121]   Alternative Activation of Macrophages: An Immunologic Functional Perspective [J].
Martinez, Fernando O. ;
Helming, Laura ;
Gordon, Siamon .
ANNUAL REVIEW OF IMMUNOLOGY, 2009, 27 :451-483
[122]   Overcoming Reduced Glucocorticoid Sensitivity in Airway Disease Molecular Mechanisms and Therapeutic Approaches [J].
Marwick, John A. ;
Adcock, Ian M. ;
Chung, Man Fan .
DRUGS, 2010, 70 (08) :929-948
[123]   Post-translational Modifications Regulate Class IIa Histone Deacetylase (HDAC) Function in Health and Disease [J].
Mathias, Rommel A. ;
Guise, Amanda J. ;
Cristea, Ileana M. .
MOLECULAR & CELLULAR PROTEOMICS, 2015, 14 (03) :456-470
[124]   Origin and physiological roles of inflammation [J].
Medzhitov, Ruslan .
NATURE, 2008, 454 (7203) :428-435
[125]   Histone deacetylases and epigenetic therapies of hematological malignancies [J].
Mercurio, Ciro ;
Minucci, Saverio ;
Pelicci, Pier Giuseppe .
PHARMACOLOGICAL RESEARCH, 2010, 62 (01) :18-34
[126]   Histone deacetylases: structural determinants of inhibitor selectivity [J].
Micelli, Carmina ;
Rastelli, Giulio .
DRUG DISCOVERY TODAY, 2015, 20 (06) :718-735
[127]   M-1/M-2 macrophages and the Th1/Th2 paradigm [J].
Mills, CD ;
Kincaid, K ;
Alt, JM ;
Heilman, MJ ;
Hill, AM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6166-6173
[128]   Sodium butyrate inhibits high glucose-induced inflammation by controlling the acetylation of NF-κB p65 in human monocytes [J].
Moon, Ha-Rin ;
Yun, Jung-Mi .
NUTRITION RESEARCH AND PRACTICE, 2023, 17 (01) :164-173
[129]   Histone deacetylase-2 controls IL-1β production through the regulation of NLRP3 expression and activation in tuberculosis infection [J].
Moreira, Josimar Dornelas ;
Iakhiaev, Alexei ;
Vankayalapati, Ramakrishna ;
Jung, Bock-Gie ;
Samten, Buka .
ISCIENCE, 2022, 25 (08)
[130]   Epigenetic Targeting of Autophagy via HDAC Inhibition in Tumor Cells: Role of p53 [J].
Mrakovcic, Maria ;
Bohner, Lauren ;
Hanisch, Marcel ;
Froehlich, Leopold F. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)